A propensity score matched comparison of blood pressure lowering in essential hypertension patients treated with antihypertensive Chinese herbal Medicine: comparing the real-world registry data vs. randomized controlled trial
Lists
Only you see this
Abstract
The current comparison demonstrated that SXC monotherapy is at least as effective in real-world settings as within the randomized controlled trial for BP lowering in patients with grade 1 hypertension.
BibTeX
@inproceedings{lai2023propensity,
author = {Xinxing Lai and Zhenghao Fang and Zhenyu Dong and Shengxian Wu and Xiao‐Hua Zhou and Ying Gao},
title = {{A propensity score matched comparison of blood pressure lowering in essential hypertension patients treated with antihypertensive Chinese herbal Medicine: comparing the real-world registry data vs. randomized controlled trial}},
booktitle = {Clinical},
year = {2023},
doi = {10.1080/10641963.2023.2249269},
}Loading related content...